MIRA – mira pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site [Yahoo! Finance]
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Form 8-K MIRA PHARMACEUTICALS, For: Nov 18
Form 144 MIRA PHARMACEUTICALS, Filed by: Aminov Erez
Form 8-K MIRA PHARMACEUTICALS, For: Nov 19
Form 10-Q MIRA PHARMACEUTICALS, For: Sep 30
Form 8-K MIRA PHARMACEUTICALS, For: Oct 25
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.